Concepedia

Publication | Closed Access

Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer

DOI

189

Citations

22

References

2008

Year

J. Lester, David Dodwell, O.P. Purohit, Sandra A. Gutcher, Susan P. Ellis, Ruth Thorpe, Janet Horsman, Janet E. Brown, R.A. Hannon, Robert E. Coleman
Clinical Cancer Research

Abstract

Monthly oral ibandronate improves bone density and normalizes bone turnover in patients treated with anastrozole.

References

YearCitations

Page 1